FDA finds quality issues at Novo’s primary Ozempic facility
Novo Nordisk A/S was recently found to have quality lapses at a drug production plant in Denmark that manufactures the popular medicines Ozempic and Wegovy. The plant, located in Kalundborg, Denmark, was found to lack information demonstrating that the water used in drug production was adequately controlled for certain microorganisms, as per a report from … Read more